Results: 1-25 | 26-33
Results: 1-25/33

Authors: Tasch, J Gong, M Sadelain, M Heston, WDW
Citation: J. Tasch et al., A unique folate hydrolase, prostate-specific membrane antigen (PSMA): A target for immunotherapy?, CR R IMMUN, 21(1-3), 2001, pp. 249-261

Authors: Bacich, DJ Pinto, JT Tong, WP Heston, WDW
Citation: Dj. Bacich et al., Cloning, expression, genomic localization, and enzymatic activities of themouse homolog of prostate-specific membrane antigen/NAALADase/folate hydrolase, MAMM GENOME, 12(2), 2001, pp. 117-123

Authors: Cozzi, PJ Malhotra, S Mcauliffe, P Kooby, DA Federoff, HJ Huryk, B Johnson, P Scardino, PT Heston, WDW Fong, Y
Citation: Pj. Cozzi et al., Intravesical oncolytic viral therapy using attenuated, replication-competent herpes simplex viruses G207 and Nv1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic model, FASEB J, 15(7), 2001, pp. 1306-1308

Authors: Watt, F Martorana, A Brookes, DE Ho, T Kingsley, E O'Keefe, DS Russell, PJ Heston, WDW Molloy, PL
Citation: F. Watt et al., A tissue-specific enhancer of the prostate-specific membrane antigen gene,FOLH1, GENOMICS, 73(3), 2001, pp. 243-254

Authors: Carroll, PR Fair, WR Grossfeld, GD Heston, WDW Lieberman, R Malkowicz, SB Stricker, HJ Sylvester, J Peehl, DM Meyer, F Hart, C
Citation: Pr. Carroll et al., Overview consensus statement, UROLOGY, 58(2A), 2001, pp. 1-4

Authors: Fair, WR Stricker, HJ Lieberman, R Bubley, GJ Trachtenberg, J Heston, WDW
Citation: Wr. Fair et al., Discussion following Dr. Hans J. Stricker's presentations, UROLOGY, 58(2A), 2001, pp. 27-27

Authors: Daniell, HW Chen, S Fair, WR Heston, WDW Pirani, JF Bubley, GJ Carroll, PR Gleave, ME
Citation: Hw. Daniell et al., Discussion following Dr. Sophie Chen's (pages 28-35) and Dr. John F. Pirani's presentations, UROLOGY, 58(2A), 2001, pp. 38-38

Authors: Fair, WR Newling, DWW Heston, WDW Trachtenberg, J Malkowicz, SB Gleave, ME
Citation: Wr. Fair et al., The role of diethylstilbestrol in the treatment of prostate cancer - Discussion, UROLOGY, 58(2A), 2001, pp. 113-113

Authors: Uchida, A O'Keefe, DS Bacich, DJ Molloy, PL Heston, WDW
Citation: A. Uchida et al., In vivo suicide gene therapy model using a newly discovered prostate-specific membrane antigen promoter/enhancer: A potential alternative approach toandrogen deprivation therapy, UROLOGY, 58(2A), 2001, pp. 132-139

Authors: Chang, SS Reuter, VE Heston, WDW Gaudin, PB
Citation: Ss. Chang et al., Comparison of anti-prostate-specific membrane antigen antibodies and otherimmunomarkers in metastatic prostate carcinoma, UROLOGY, 57(6), 2001, pp. 1179-1183

Authors: Chang, SS Reuter, VE Heston, WDW Gaudin, PB
Citation: Ss. Chang et al., Metastatic renal cell carcinoma neovasculature expresses prostate-specificmembrane antigen, UROLOGY, 57(4), 2001, pp. 801-805

Authors: O'Keefe, DS Bacich, DJ Heston, WDW
Citation: Ds. O'Keefe et al., Prostate specific membrane antigen, CONT CANC R, 2001, pp. 307-326

Authors: Gong, MC Chang, SS Watt, F O'Keefe, DS Bacich, DJ Uchida, A Bander, NH Reuter, VE Gaudin, PB Molloy, PL Sadelian, M Heston, WDW
Citation: Mc. Gong et al., Overview of evolving strategies incorporating prostate-specific membrane antigen as target for therapy, MOL UROL, 4(3), 2000, pp. 217-222

Authors: Howell, S Heston, WDW Sakr, W Bostwick, D Bruchovsky, N Garnick, M Stone, N Garzotto, M
Citation: S. Howell et al., Overview of evolving strategies incorporating prostate-specific membrane antigen as target for therapy - Open discussion following Dr. Heston's presentation, MOL UROL, 4(3), 2000, pp. 223-223

Authors: Larchian, WA Horiguchi, Y Nair, SK Fair, WR Heston, WDW Gilboa, E
Citation: Wa. Larchian et al., Effectiveness of combined interleukin 2 and B7.1 vaccination strategy is dependent on the sequence and order: A liposome-mediated gene therapy treatment for bladder cancer, CLIN CANC R, 6(7), 2000, pp. 2913-2920

Authors: Kelly, WK Osman, I Reuter, VE Curley, T Heston, WDW Nanus, DM Scher, HI
Citation: Wk. Kelly et al., The development of biologic end points in patients treated with differentiation agents: An experience of retinoids in prostate cancer, CLIN CANC R, 6(3), 2000, pp. 838-846

Authors: Horiguchi, Y Larchian, WA Kaplinsky, R Fair, WR Heston, WDW
Citation: Y. Horiguchi et al., Intravesical liposome-mediated interleukin-2 gene therapy in orthotopic murine bladder cancer model, GENE THER, 7(10), 2000, pp. 844-851

Authors: Pinto, JT Qiao, CH Xing, J Suffoletto, BP Schubert, KB Rivlin, RS Huryk, RF Bacich, DJ Heston, WDW
Citation: Jt. Pinto et al., Alterations of prostate biomarker expression and testosterone utilization in human LNCaP prostatic carcinoma cells by garlic-derived S-allylmercaptocysteine, PROSTATE, 45(4), 2000, pp. 304-314

Authors: O'Keefe, DS Uchida, A Bacich, DJ Watt, FB Martorana, A Molloy, PL Heston, WDW
Citation: Ds. O'Keefe et al., Prostate-specific suicide gene therapy using the prostate-specific membrane antigen promoter and enhancer, PROSTATE, 45(2), 2000, pp. 149-157

Authors: Chang, SS Gaudin, PB Reuter, VE Heston, WDW
Citation: Ss. Chang et al., Prostate-specific membrane antigen: Present and future application, UROLOGY, 55(5), 2000, pp. 622-629

Authors: Chang, SS Reuter, VE Heston, WDW Hutchinson, B Grauer, LS Gaudin, PB
Citation: Ss. Chang et al., Short term neoadjuvant androgen deprivation therapy does not affect prostate specific membrane antigen expression in prostate tissues, CANCER, 88(2), 2000, pp. 407-415

Authors: Chang, SS Gaudin, PB Reuter, VE O'Keefe, DS Bacich, DJ Heston, WDW
Citation: Ss. Chang et al., Prostate-specific membrane antigen: Much more than a prostate cancer marker, MOL UROL, 3(3), 1999, pp. 313-319

Authors: Cozzi, PJ Bajorin, DF Tong, W Nguyen, H Scott, J Heston, WDW Dalbagni, G
Citation: Pj. Cozzi et al., Toxicology and pharmacokinetics of intravesical gemcitabine: A preclinicalstudy in dogs, CLIN CANC R, 5(9), 1999, pp. 2629-2637

Authors: Chang, SS O'Keefe, DS Bacich, DJ Reuter, VE Heston, WDW Gaudin, PB
Citation: Ss. Chang et al., Prostate-specific membrane antigen is produced in tumor-associated neovasculature, CLIN CANC R, 5(10), 1999, pp. 2674-2681

Authors: Gong, MC Chang, SS Sadelain, M Bander, NH Heston, WDW
Citation: Mc. Gong et al., Prostate-specific membrane antigen (PSMA)-specific monoclonal antibodies in the treatment of prostate and other cancers, CANC METAST, 18(4), 1999, pp. 483-490
Risultati: 1-25 | 26-33